Busulfan and Melphalan Versus Carboplatin, Etoposide, and Melphalan as High-Dose Chemotherapy for High-Risk Neuroblastoma (Hr-Nbl1/Siopen): an International, Randomised, Multi-Arm, Open-Label, Phase 3 Trial

AuthID
P-00M-K04
28
Author(s)
Poetschger, U
·
Pearson, ADJ
·
Luksch, R
·
Castel, V
·
Yaniv, I
·
Papadakis, V
·
Laureys, G
·
[+2]·
[+2]·
[+4]·
Ambros, PF
·
Holmes, K
·
Gaze, M
·
Schreier, G
·
Garaventa, A
·
Vassal, G
·
Michon, J
·
Valteau Couanet, D
1
Group Author(s)
SIOP Europe Neuroblastoma Grp
Document Type
Article
Year published
2017
Published
in LANCET ONCOLOGY, ISSN: 1470-2045
Volume: 18, Issue: 4, Pages: 500-514 (15)
Indexing
Publication Identifiers
Wos: WOS:000397762000038
Source Identifiers
ISSN: 1470-2045
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Ladenstein, R;   2 Poetschger, U;   3 Pearson, ADJ;
4 Brock, P;   5 Luksch, R;   6 Castel, V;
7 Yaniv, I;   8 Papadakis, V;   9 Laureys, G;
10 Malis, J;   11 Balwierz, W;   12 Ruud, E;
13 Kogner, P;   14 Schroeder, H;   15 de Lacerda, AF;
16 Beck Popovic, M;   17 Bician, P;   18 Garami, M;
19 Trahair, T;   20 Canete, A;   21 Ambros, PF;
22 Holmes, K;   23 Gaze, M;   24 Schreier, G;
25 Garaventa, A;   26 Vassal, G;   27 Michon, J;
28 Valteau Couanet, D;